CVS HEALTH CORP (CVS.DE) Stock Balance Sheet
Europe • Frankfurt Stock Exchange • FRA:CVS • US1266501006
66.16 EUR
+1.35 (+2.08%)
Last: Feb 6, 2026, 07:00 PM
| MRQ (2025-9-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 9.10B | 8.59B | 8.20B | 12.95B | 9.41B | |||
| Marketable Securities | 2.13B | 2.41B | 3.26B | 2.78B | 3.12B | |||
| Receivables | 43.86B | 36.47B | 35.23B | 27.28B | 24.43B | |||
| Inventories | 18.96B | 18.11B | 18.02B | 19.09B | 17.76B | |||
| Other Current Assets | 3.06B | 3.08B | 3.15B | 3.54B | 5.29B | |||
| Total Current Assets | 77.11B | 68.64B | 67.86B | 65.63B | 60.01B | |||
| Non-Current Assets | ||||||||
| PPE Net | 28.11B | 28.94B | 30.43B | 30.75B | 32.02B | |||
| Investments And Advances | 31.55B | 28.93B | 23.02B | 21.10B | 23.02B | |||
| Goodwill | 85.48B | 91.27B | 91.27B | 78.15B | 79.12B | |||
| Intangibles | 25.98B | 27.32B | 29.23B | 24.80B | 29.03B | |||
| Other Non-Current Assets | 7.09B | 8.10B | 7.91B | 7.85B | 9.80B | |||
| Total Non-Current Assets | 178.22B | 184.57B | 181.87B | 162.64B | 172.99B | |||
| TOTAL ASSETS | 255.33B | 253.22B | 249.73B | 228.28B | 233.00B | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 1.25B | 2.12B | 200.00M | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 4.08B | 3.62B | 2.77B | 1.78B | 4.21B | |||
| Accrued Expenses | 25.27B | 22.42B | 23.78B | 20.35B | 19.23B | |||
| Accounts Payable | 60.95B | 55.12B | 49.82B | 44.40B | 38.68B | |||
| Other Current Liabilities | 1.15B | 1.33B | 2.62B | 2.89B | 5.69B | |||
| Total Current Liabilities | 92.69B | 84.61B | 79.19B | 69.42B | 67.81B | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 60.51B | 60.53B | 58.64B | 50.48B | 51.97B | |||
| Deferred Taxes/Income | 3.55B | 3.81B | 4.31B | 4.02B | 6.27B | |||
| Other Non-Current Liabilities | 25.47B | 28.54B | 30.95B | 32.59B | 31.57B | |||
| Total Non-Current Liabilities | 89.70B | 93.05B | 94.08B | 87.39B | 90.12B | |||
| TOTAL LIABILITIES | 182.40B | 177.66B | 173.27B | 156.81B | 157.92B | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | 59.11B | 62.84B | 61.60B | 56.40B | 54.91B | |||
| Additional Paid In Capital | N/A | N/A | N/A | N/A | N/A | |||
| Minority Interest | 182.00M | 170.00M | 175.00M | 300.00M | 306.00M | |||
| Common Shares | 50.18B | 49.66B | 48.99B | 48.19B | 47.38B | |||
| Treasury Stock | -36.78B | -36.82B | -33.84B | -31.86B | -28.17B | |||
| Other Shareholders' Equity | 220.00M | 279.00M | 132.00M | 255.00M | 187.00M | |||
| Shares Outstanding | 1.27B | 1.26B | 1.29B | 1.30B | 1.32B | |||
| Tangible Book Value per Share | -30.34 | -34.15 | -34.20 | -24.22 | -25.02 | |||
| Total Shareholders' Equity | 72.93B | 75.56B | 76.46B | 71.47B | 75.08B | |||
| TOTAL LIABILITIES AND EQUITY | 255.33B | 253.22B | 249.73B | 228.28B | 233.00B | |||
| Statistics | ||||||||
| Debt/Equity | 0.85 | 0.83 | 0.77 | 0.71 | 0.69 | |||
| Current Ratio | 0.83 | 0.81 | 0.86 | 0.95 | 0.88 | |||
| Return On Assets (ROA) | 0.18% | 1.82% | 3.34% | 1.89% | 3.43% | |||
| Return On Equity (ROE) | 0.64% | 6.11% | 10.91% | 6.03% | 10.66% | |||
| Return On Invested Capital (ROIC) | 4.90% | 4.39% | 6.60% | 7.66% | 6.89% | |||
| Return On Invested Capital Ex Cash (ROICexc) | 5.26% | 4.70% | 7.08% | 8.51% | 7.46% | |||
| Return On Invested Capital Ex Cash + Goodwill (ROICexgc) | 19.51% | 18.24% | 29.08% | 30.30% | 25.57% | |||
All data in USD , ROIC based on taxRate of 0.25